Blue Water Biotech Common Stock

The latest common stock for BWV is $27 as of March 2026. That compares with $370 in the prior-year period — down 92.7% year over year. Investors often review this figure alongside Blue Water Biotech's historical trend and sector peers before judging valuation or financial health.

Over the past year, BWV's common stock moved from $370 to $27 — a 92.7% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Blue Water Biotech's operating scale or balance-sheet position.

A common stock figure of $27 for BWV is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting BWV's common stock ($27), review year-over-year change from $370, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.